• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Methods for study of fluphenazine kinetics in man.

作者信息

Whelpton R, Curry S H

出版信息

J Pharm Pharmacol. 1976 Dec;28(12):869-73. doi: 10.1111/j.2042-7158.1976.tb04082.x.

DOI:10.1111/j.2042-7158.1976.tb04082.x
PMID:12260
Abstract

Fluphenazine and its principal metabolites, fluphenazine sulphoxide, and 7-hydroxyfluphenazine were identified and quantified in human plasma, urine and faeces following intramuscular and oral administration of 14C-fluphenazine dihydrochloride. The presence of a conjugate fraction was also noted. Unmetabolized fluphenazine was selectively extracted into n-heptane. The metabolites were separated by solvent extraction into toluene. Conjugates were hydrolysed back to fluphenazine, fluphenazne sulphoxide and 7-hydroxyfluphenazine. Fluphenazine and fluphenazine conjugates were also measured in the urine of patients receiving long term non-radioactive fluphenazine decanoate therapy. The urinary excretion rate of the conjugate fraction was systematically related to the plasma concentration, regardless of urine flow rate or pH, providing a convenient method for the assessment of fluphenazine kinetics by urinary excretion studies not involving administration of labelled drug.

摘要

相似文献

1
Methods for study of fluphenazine kinetics in man.
J Pharm Pharmacol. 1976 Dec;28(12):869-73. doi: 10.1111/j.2042-7158.1976.tb04082.x.
2
Kinetics of fluphenazine after fluphenazine dihydrochloride, enanthate and decanoate administration to man.给人服用盐酸氟奋乃静、庚酸氟奋乃静和癸酸氟奋乃静后氟奋乃静的动力学
Br J Clin Pharmacol. 1979 Apr;7(4):325-31. doi: 10.1111/j.1365-2125.1979.tb00941.x.
3
Fluphenazine enanthate and fluphenazine decanoate: intramuscular injection and esterification as requirements for slow - release characteristics in dogs.
J Pharm Sci. 1976 Sep;65(9):1310-5. doi: 10.1002/jps.2600650912.
4
Excretion and biotransformation of the enanthate ester of fluphenazine- 14 C by the dog.氟奋乃静庚酸酯-14C在犬体内的排泄及生物转化
J Pharm Sci. 1971 Jun;60(6):829-33. doi: 10.1002/jps.2600600606.
5
Radioimmunoassay for 7-hydroxy metabolite of fluphenazine and its application to plasma level monitoring in schizophrenic patients treated long term with oral and depot fluphenazine.氟奋乃静7-羟基代谢物的放射免疫测定及其在长期口服和长效氟奋乃静治疗的精神分裂症患者血浆水平监测中的应用。
Ther Drug Monit. 1994 Feb;16(1):21-9. doi: 10.1097/00007691-199402000-00003.
6
Kinetics of oral fluphenazine disposition in humans by GC-MS.气相色谱-质谱联用法定量分析人口服氟奋乃静的处置动力学
Eur J Clin Pharmacol. 1983;25(5):709-11. doi: 10.1007/BF00542363.
7
Identification of phase-I and phase-II metabolites of fluphenazine in rat bile. Intact glucuronide and sulfate conjugates.
Drug Metab Dispos. 1991 Jan-Feb;19(1):188-93.
8
Therapeutic monitoring of steady-state plasma levels of the N4'-oxide metabolite of fluphenazine in chronically treated schizophrenic patients determined by a specific and sensitive radioimmunoassay.通过一种特异性且灵敏的放射免疫分析法测定慢性治疗的精神分裂症患者中氟奋乃静N4'-氧化物代谢物的稳态血浆水平的治疗监测。
Ther Drug Monit. 1990 May;12(3):268-76. doi: 10.1097/00007691-199005000-00010.
9
Release and elimination of 14C-fluphenazine enanthate and decanoate esters administered in sesame oil to dogs.将14C-氟奋乃静庚酸酯和癸酸酯以芝麻油形式给狗注射后的释放与消除情况。
J Pharm Sci. 1976 Apr;65(4):502-507. doi: 10.1002/jps.2600650407.
10
A highly sensitive and specific radioimmunoassay for quantitation of plasma fluphenazine.
J Pharm Sci. 1988 Mar;77(3):255-8. doi: 10.1002/jps.2600770315.

引用本文的文献

1
Plasma levels of fluphenazine during fluphenazine decanoate treatment in schizophrenia.精神分裂症患者癸酸氟奋乃静治疗期间的血浆氟奋乃静水平。
Psychopharmacology (Berl). 1985;87(1):55-8. doi: 10.1007/BF00431778.
2
Variation in the single dose pharmacokinetics of fluphenazine in psychiatric patients.氟奋乃静在精神科患者中的单剂量药代动力学变异。
Psychopharmacology (Berl). 1988;96(2):206-11. doi: 10.1007/BF00177561.
3
The sulfoxidation of fluphenazine in schizophrenic patients maintained on fluphenazine decanoate.癸酸氟奋乃静维持治疗的精神分裂症患者中氟奋乃静的硫氧化作用
Psychopharmacology (Berl). 1987;93(3):369-73. doi: 10.1007/BF00187259.
4
Anti-apomorphine effects of phenothiazine drug metabolites.
Psychopharmacology (Berl). 1987;92(1):68-72. doi: 10.1007/BF00215481.
5
Clinical pharmacokinetics of the depot antipsychotics.长效抗精神病药物的临床药代动力学
Clin Pharmacokinet. 1985 Jul-Aug;10(4):315-33. doi: 10.2165/00003088-198510040-00003.
6
Radioimmunoassay for fluphenazine in human plasma.人血浆中氟奋乃静的放射免疫分析
Br J Clin Pharmacol. 1978 Mar;5(3):265-8. doi: 10.1111/j.1365-2125.1978.tb01636.x.
7
Kinetics of fluphenazine after fluphenazine dihydrochloride, enanthate and decanoate administration to man.给人服用盐酸氟奋乃静、庚酸氟奋乃静和癸酸氟奋乃静后氟奋乃静的动力学
Br J Clin Pharmacol. 1979 Apr;7(4):325-31. doi: 10.1111/j.1365-2125.1979.tb00941.x.